Citadel Advisors
CFRX

Citadel Advisors’s ContraFect Corporation CFRX Stock Holding History

Citadel Advisors’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-291
Closed -$2.24K – 16251
2022
Q4 		$2.24K Sell
291
-168
-37% -$1.94K ﹤0.01% 14363
2022
Q3 		$6K Sell
459
-484
-51% -$24.4K ﹤0.01% 12370
2022
Q2 		$231K Buy
943
+307
+48% +$86.7K ﹤0.01% 10401
2022
Q1 		$186K Sell
636
-1,578
-71% -$384K ﹤0.01% 11625
2021
Q4 		$466K Buy
2,214
+1,955
+755% +$537K ﹤0.01% 9875
2021
Q3 		$84K Sell
259
-254
-50% -$79K ﹤0.01% 13037
2021
Q2 		$180K Buy
513
+119
+30% +$39K ﹤0.01% 12289
2021
Q1 		$151K Buy
394
+168
+74% +$72.5K ﹤0.01% 12032
2020
Q4 		$91K Buy
+226
New +$97.8K ﹤0.01% 10280

Other funds holding CFRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Citadel Advisors's CFRX Position: Q1 2023 in Review

Citadel Advisors sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 940 shares — an estimated $7.21K sold.

Citadel Advisors first reported a position in CFRX in Q3 2017 and held it in 12 quarters. The position peaked at $314K in Q2 2021. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • Citadel Advisors reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 940 ContraFect Corporation shares in Q1 2023, an estimated $7.21K.
  • Citadel Advisors first reported a position in ContraFect Corporation in Q3 2017 and held it in 12 quarters.
  • Citadel Advisors's ContraFect Corporation position peaked at $314K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.